Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between telomere length and cognitive function among cognitively unimpaired individuals at risk of Alzheimer's disease.
Rodríguez-Fernández B, Sánchez-Benavides G, Genius P, Minguillon C, Fauria K, De Vivo I, Navarro A, Molinuevo JL, Gispert JD, Sala-Vila A, Vilor-Tejedor N, Crous-Bou M; ALFA study. Rodríguez-Fernández B, et al. Among authors: crous bou m. Neurobiol Aging. 2024 Sep;141:140-150. doi: 10.1016/j.neurobiolaging.2024.05.015. Epub 2024 Jun 1. Neurobiol Aging. 2024. PMID: 38936230 Free article.
Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals: Draft for internal testing.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Peláez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Aggett P, Crous Bou M, Cubadda F, de Sesmaisons Lecarré A, Martino L, Naska A. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al. EFSA J. 2022 Jan 24;20(1):e200102. doi: 10.2903/j.efsa.2022.e200102. eCollection 2022 Jan. EFSA J. 2022. PMID: 35106096 Free PMC article.
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
Mukama T, Fortner RT, Katzke V, Hynes LC, Petrera A, Hauck SM, Johnson T, Schulze M, Schiborn C, Rostgaard-Hansen AL, Tjønneland A, Overvad K, Pérez MJS, Crous-Bou M, Chirlaque MD, Amiano P, Ardanaz E, Watts EL, Travis RC, Sacerdote C, Grioni S, Masala G, Signoriello S, Tumino R, Gram IT, Sandanger TM, Sartor H, Lundin E, Idahl A, Heath AK, Dossus L, Weiderpass E, Kaaks R. Mukama T, et al. Br J Cancer. 2022 May;126(9):1301-1309. doi: 10.1038/s41416-021-01697-z. Epub 2022 Jan 14. Br J Cancer. 2022. PMID: 35031764 Free PMC article.
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study.
Córdova R, Mayén AL, Knaze V, Aglago EK, Schalkwijk C, Wagner KH, Overvad K, Tjønneland A, Kyrø C, Katzke VA, Cornet CL, Schulze MB, Birukov A, Palli D, Grioni S, Pasanisi F, Catalano A, Sandanger TM, Gram IT, Skeie G, Crous-Bou M, Molina-Montes E, Amiano P, Colorado-Yohar SM, Ardanaz E, Drake I, Manjer J, Johansson I, Esberg A, Perez-Cornago A, Weiderpass E, Jenab M, Freisling H. Córdova R, et al. Cancer Commun (Lond). 2022 Oct;42(10):1041-1045. doi: 10.1002/cac2.12343. Epub 2022 Aug 4. Cancer Commun (Lond). 2022. PMID: 35924960 Free PMC article. No abstract available.
Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
Mao Z, Baker JR, Takeuchi M, Hyogo H, Tjønneland A, Eriksen AK, Severi G, Rothwell J, Laouali N, Katzke V, Kaaks R, Schulze MB, Palli D, Sieri S, de Magistris MS, Tumino R, Sacerdote C, Derksen JWG, Gram IT, Skeie G, Sandanger TM, Quirós JR, Crous-Bou M, Sánchez MJ, Amiano P, Colorado-Yohar SM, Guevara M, Harlid S, Johansson I, Perez-Cornago A, Freisling H, Gunter M, Weiderpass E, Heath AK, Aglago E, Jenab M, Fedirko V. Mao Z, et al. Int J Cancer. 2023 Jun 1;152(11):2257-2268. doi: 10.1002/ijc.34449. Epub 2023 Mar 20. Int J Cancer. 2023. PMID: 36715363
Genome-wide association study of endometrial cancer in E2C2.
De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N; Australian National Endometrial Cancer Study Group; Attia J, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Dunning AM, Easton DF, Friedenreich CM, Garcia-Closas M, Gaudet MM, Haiman C, Hankinson SE, Hartge P, Henderson BE, Holliday E, Horn-Ross PL, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Long J, Lu L, Magliocco AM, McEvoy M, O'Mara TA, Orlow I, Painter JN, Pooler L, Rastogi R, Rebbeck TR, Risch H, Sacerdote C, Schumacher F, Scott RJ, Sheng X, Shu XO, Spurdle AB, Thompson D, Vanden Berg D, Weiss NS, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Chanock S, Kraft P. De Vivo I, et al. Hum Genet. 2014 Feb;133(2):211-24. doi: 10.1007/s00439-013-1369-1. Epub 2013 Oct 6. Hum Genet. 2014. PMID: 24096698 Free PMC article.
Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction.
Busch EL, Crous-Bou M, Prescott J, Chen MM, Downing MJ, Rosner BA, Mutter GL, De Vivo I. Busch EL, et al. Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):727-735. doi: 10.1158/1055-9965.EPI-16-0821. Epub 2017 Jan 4. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28052940 Free PMC article.
102 results